Investigating Barriers in HIV-Testing Oncology Patients: The IBITOP Study, Phase I

BACKGROUND. Although the prevalence of non-AIDS-defining cancers (non-ADCs) among people living with HIV is rising, we observed HIV testing rates below 5% at our oncology center, against a regional HIV prevalence of 0.2%–0.4%. We performed the Investigating Barriers in HIV-Testing Oncology Patients...

Full description

Saved in:
Bibliographic Details
Published in:Oncologist
Main Authors: Merz, Laurent, Zimmermann, Stefan, Peters, Solange, Cavassini, Matthias, Darling, Katharine E.A.
Format: Artigo
Language:Inglês
Published: AlphaMed Press 2016
Subjects:
Community Outreach
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5061530/
https://ncbi.nlm.nih.gov/pubmed/27440062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0107
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items